Catalent to acquire Juniper Pharmaceuticals for $11.50/share

Source: Dukascopy Bank SA
On Tuesday, the US drug contract producer stated it would acquire Juniper Pharmaceuticals for $11.50 a share in cash, valuing the company at around $127.7M.
Back to articles

Actual Topics

Tue, 03 Jul 2018 10:37:37 GMT

KazMunayGaz's deal with China's CEFC falls apart

According to Reuters, the state energy company KazMunayGaz's deal to sell its 51% majority stake in Romania's arm to China's energy titam CEFC has collapsed.

Tue, 03 Jul 2018 09:28:32 GMT

Austria prepares to protect its borders

The Austrian government has announced that the country is ready to protect its southern border, if a migration deal is made within Germany.

Subscribe to "Fundamental Analysis" feed

Subscribe
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.